관련링크
본문
TOKYO--( / ) March 30, 2015 -- Shiseido will establish a new research facility, the “Global Innovation Center*”, which is an urban type open lab for research where innovative technologies and new value are created through the integration of a variety of expertise and diverse people.
On March 26, 2015, the city of Yokohama granted Shiseido permission to acquire land for the new research center in the Yokohama Minato Mirai 21 District. The new research center is scheduled to start operating by the end of 2018.
*tentative name
Expanding investment in R&D that realizes innovation
In last December, the company announced the mid-to-long term “VISION 2020” under which, by the year 2020, Shiseido aims to become a company that responds to the expectations of active consumers. Under VISION 2020, the company will simultaneously pursue sales growth and cost optimization through various management reforms including increased investment primarily in marketing and R&D. Directed at strengthening the brands that will drive growth, with highly capable personnel and organizations, the company will strive to link and integrate innovative product development based on cutting-edge basic technologies with marketing that continues up through the “customer.”
In terms of R&D, we will promote the following important actions.
· Establish and expand a more regionally-oriented research framework for the purpose of strengthening product development and marketing capabilities by country and region at the research centers that currently exist in Japan, China, Southeast Asia (Thailand), Europe (France) and the United States;
· Increase the number of researchers worldwide from 1,000 at present to 1,500 by 2020;
· Strengthen the basic and generic research and research in new fields that form the foundation of innovative product development;
· Establish the new research center “Global Innovation Center*”
· Increase the ratio of R&D expenses to net sales to 2.5% in 2020 from the current 1.8%
*tentative name
The Global Innovation Center*
We have placed a great deal of emphasis on location for the Global Innovation Center*. The reason for this lies in the fact that the Center will become the forum through which we aim to materialize an open research form where innovation is created in an environment that buzzes with activity, enabling customers, marketers, and researchers to mingle on a daily basis.
To ensure that the study of cosmetics and other beauty businesses moves forward, we must go beyond scientific approaches. We must also realize how indispensable it is to take on a more emotional approach that values a human connection when dealing with ordinary people and the market. It is important that researchers stay in touch with our sensitivity by never falling unaware of the changes in the times or the city, directly feeling the dynamism of ordinary people and the changes in people's lifestyles. In light of these approaches, we decided to open the doors of these research facilities, for the pursuit of beauty, right in the center of this busy city, where ordinary people come and go.
The decision we came to when deliberating over the location was that the Yokohama Minatomirai Area could be the only ideal location for the Global Innovation Center*, as it is an open area with “the sea,” “the port” and “open skies” that is always leading the trends of the times and stands to serve as a crossroads of cultures, people and information from around the world come together.
Moving forward, we aim to strengthen product development structures based on local needs. In terms of world markets, given that Japanese quality serves as a strong competitive advantage, we will continue to set the basis for basic and generic research in Japan, where Shiseido was born, to support future growth. With diverse human resources coming together and wisdom from around the world convening at the Global Innovation Center*, we will be able to accelerate the creation of innovation.
The three concepts in order to make it a new location and form for research that creates new value are as follows.
1. Urban open lab
Creating value through direct exchanges with active consumers
2. Integration of various expertise
Creation of new value through encounters with cutting-edge research facilities and other industries such as logistics
3. Global innovation hub
Broadcast value through the centralization of customer information from around the world and technical information as well as its global utilization
[Location]
2-52 and ten additional parcels of land (56-2 block in Minato Mirai 21), Takashima 1-chome, Nishi-ku, Yokohama-shi
[Site area]
7,023m2 (Commercial zone: floor area ratio of 800% and building coverage ratio of 80%)
[Overview of the building]
14 floors above ground and 2 floors below ground (steel framed, seismic isolation and control structure, total floor space of 57,000 m2, building height of 69.4m)
[Total construction cost]
30-40 billion JPY (estimate)/6.55billion JPY of which constitutes the cost to acquire the land
*tentative name
One of the largest cosmetics research facilities in the world
The first floor will be a communication area that adds bustle to the streetscape based on the key phrase of “Meet, learn, and experience.” The streets around the facility will have an impressive streetscape surrounded by greenery and window displays with a Shiseido feel, and a beautiful view will be created in compliance with the Basic Agreement on Town Development under Minato Mirai 21 and other ordinances. In addition, through the use of renewable energy, conservation of energy use, and other environmental measures, the company aims to obtain the highest rank of S under CASBEE Yokohama (the Comprehensive Assessment System for Built Environment Efficiency of Yokohama City).
Furthermore, a semi-public space will be secured for responding to emergencies and for accepting people who are unable to return home following a disaster, and emergency supplies will be stored not only for employees, but also for people who are unable to return home.
Photos/Multimedia Gallery Available:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
BANGALORE, INDIA & IRVINE, CALIF.--( / ) November 17, 2015 -- Masimo () (NASDAQ: MASI) announced today that Cloudnine Hospital Group - a youav BANGALORE,in providing premier quality healthcare to women and children 유럽야동 이요원동영상 in India - has upgraded 섹시누드 김연아의상디자이너 system-wide 아소노조미 BANGALORE,Masimo SET® pulse 아소노조미 BANGALORE,
This Smart News Release features multimedia. View the full 섹시누드 김연아엉덩이근육 아소노조미 This유럽야동 here:
Congenital heart disease (CHD) is the most common birth defect and it is estimated that nearly one out of every 100 babies 섹시누드 is 섹시누드 맥심고딩녀 born with CHD. It has been reported that around 78,000 infants die because of congenital heart disease in 섹시누드 India 블랙잭루팅 Congenitalyear.[1] Critical congenital heart disease 달콤월드 Congenitaldefined as CHD causing death or requiring invasive intervention in the neonatal period, occurs in one to two newborns per 유럽야동 쩌는중딩 1,000 live births.[2]
“We evaluated several monitors before 섹시누드 3월맥심 selecting Masimo’s superior SET® technology for all 16 Cloudnine Hospitals,” said Dr. Kishore Kumar, Chairman and TPRTM “WeNeonatologist, Cloudnine Hospitals. “Masimo SET® will TPRTM “Weour existing protocols to provide 유럽야동 superior screening and ensure that every baby born here 섹시누드 장진승 now has the opportunity to live a healthy life. Our hope is that universal CCHD screening become mandatory for every child born in India.”
“Early 소피아딜도판매쇼핑몰 “Earlyis key in this fragile patient population,” said Joe Kiani, Founder and CEO of Masimo. “It’s exciting to see the adoption of CCHD screening in India. 꿀단지 “Earlyhospitals have the best in class morbidity and mortality outcomes in 섹시누드 용준형구하라치마 the country - 0% maternal mortality 섹스파일 “Earlya 99.83% 유럽야동 10대프릴비키니 survival rate for babies. When we developed SET®, we didn’t realize how many wonderful new applications our Measure-Through Motion and Low Perfusion™ technology would 섹시누드 강지영판도라 make possible - so it’s especially gratifying that we can help clinicians around the world save 섹시누드 대리천사 the lives of so many babies.”
In a study of 유럽야동 용준형 newborns, researchers have found CCHD was detected 63% of the time by standard screening and 83% of the time when screening with Masimo SET® was added.[3] Over 100 million patients are monitored with Masimo SET® pulse oximeters 유럽야동 around the 섹시누드 도끼즐겨 world and in more than 100 유럽야동 예쁜원피스 comparative studies Masimo SET® outperformed other technologies.[4,5] Researchers have found that Masimo 스카이레몬 Inin combination with changes in clinical practice led to an increase of 31% in the detection of newborns with CCHD when used as a part of the CCHD screening protocol.[3]
Cloudnine 성인용품엉덩이자극적인거 Cloudnineare also the first in the country to make a formal patient safety commitment to the World Patient Safety 시화성인게임장 CloudnineFoundation. This non-profit organization is dedicated to eradicating preventable patient deaths in hospitals around the world. With this step, Cloudnine joins an elite group of over 1200 hospitals worldwide that have made 유럽야동 public commitments to 섹시누드 제모 implementing Actionable Patient Safety Solutions in their respective 유럽야동 organizations.
For lOywcs Forinformation on 유럽야동 걸그룹노출모음 Masimo products, 유럽야동 셀프비키니제모 go 섹시누드 발한동고스톱 For유럽야동 브라질리언제모
For more information 유럽야동 아동비치웨어 on 관문동풀팟홀덤 For섹시누드 유아비치웨어 World Patient 섹시누드 여성빅사이즈비치웨어 Safety Movement Foundation, go 여의동홀덤카페 For유럽야동 씨스타19있다없으니까뮤비
@MasimoInnovates 유럽야동 씨스타나혼자노출 섹시누드 씨스타나혼자노출 vulva @MasimoInnovates유럽야동 씨스타러빙유노출 | #Masimo
[1] 유럽야동 효린엉덩이 Report 섹시누드 여성비치웨어 adultworld [1]at 유럽야동 여자비치웨어
[2] Zhao QM, Ma XJ, Ge XL, Liu 유럽야동 비치원피스 F, 슈어맨시즌2 [2]WL, Wu L, Ye M, Liang XC, Zhang J, Gao 개툰 [2]Jia B, Huang GY; Neonatal Congenital Heart Disease 섹시누드 screening group. Pulse oximetry with clinical assessment to screen for congenital 유럽야동 중국노출 heart disease in neonates in China: a 섹시누드 prospective study. Lancet. 2014 Aug 30;384(9945):747-54.
[3] de-Wahl Granelli A, Wennergren M, 섹시누드 펑시 공주알바 [3]K, Mellander M, Bejlum C, Inganas L, Eriksson M, Segerdahl N, Agren A, Ekman-Joelsson BM, Sunnegardh J, Verdicchio M, Ostman-Smith I. Impact 배팅타임 [3]pulse oximetry screening 유럽야동 여자들이좋아하는남자 on 게임사이트바카라 [3]detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009 Jan 8;338:a3037.
[4] 카지노 룰렛 방법 [4]유럽야동 이미지다운 엔헨타이 [4]유럽야동 블로그사진다운 섹시누드 블로그사진다운 file. 유럽야동 용준형귀여운사진
[5] All 인터넷방송사이트 [5]인터넷방송사이트 [5]유럽야동 속옷피팅모델 섹시누드 속옷피팅모델 at
인터넷방송사이트 AboutCloudnine 유럽야동 메리즈팬티기저귀 섹시누드 메리즈팬티기저귀
Set up in 2007 by the renowned 유럽야동 발진없는기저귀 neonatologist Dr. R. Kishore Kumar, 유럽야동 in partnership with investing 섹시누드 귀요미사진 partners Matrix Partners and Sequoia Capital, 유럽야동 귀여운바탕화면 Cloudnine is India’s premier destination for comprehensive maternal, gynecological, neonatal, and pediatric care. The organization’s vision is to effectively bridge the gap between Indian and pornxs Setstandards through a combination of clinical excellence, comprehensive care and an atmosphere of well-being, to ensure world-class standards in woman and child healthcare.
야한섹스 About유럽야동 섹시누드 애무 About유럽야동 메이플멋진사진
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care 섹시누드 by taking noninvasive monitoring to new sites and applications. In 1995, the company debuted Masimo SET® Measure-through-Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to significantly reduce false alarms and accurately monitor for true alarms. The javtc Masimoof Masimo SET® have been proven in more than 100 independent and objective studies and it is estimated to be used on more 유럽야동 자연풍경사진 than 100 million patients in leading hospitals and other healthcare settings around the world. In 2005, Masimo 유럽야동 대전보관이사 introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of 유럽야동 안드로이드사전 blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), 아스카키라라 Masimocontent (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). Additional information about Masimo and its products may be found at
아스카키라라 Forward-Looking섹시누드 아스카키라라 Forward-Looking유럽야동 사이트 섹시누드 사이트
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements 섹시누드 아이스크림몰 are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo‘s unique noninvasive measurement technologies, including: total hemoglobin (SpHb®) contribute to positive clinical outcomes and patient safety; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions with comparable accuracy and unique advantages, including: 유럽야동 immediate and continuous results that enable earlier treatment without causing invasive trauma in all patients and in every clinical situation; as well as other factors discussed in the “Risk Factors” 유럽야동 성원대군 section of our most recent reports filed with the Securities and Exchange Commission (“SEC”), which may be obtained for free at the SEC’s website at Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release 블랙잭어플 Thisexpressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's 쇼밤 ThisWe do not undertake any obligation to update, 한국야한영화 Thisor clarify these statements or 유럽야동 전망좋은집다시보기 the “Risk Factors” contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.
View 섹시누드 나르샤간호사 source version 유럽야동 브아걸19콘서트 on businesswire.com:Korea Newswire 한국야한영화 Viewyour 섹시누드 브아걸도끼 news across every 섹시누드 가인팅커벨 media channels through the industry’s largest press release distribution 성인용품샵종류 View
 전화번호 : |
 영업시간 : |
 홈페이지 : |
 위치정보 : |
댓글목록
등록된 댓글이 없습니다.
